Stay updated on Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial page.

Latest updates to the Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record history shows a new revision entry v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry 'Revision: v3.4.2' was added to the Study Record Versions list. The previously displayed government funding operating status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check44 days agoChange DetectedA government funding notice banner was added and the revision label updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.7%

- Check51 days agoChange DetectedAdded a glossary display and color-coded highlights to the study record history to distinguish additions (green) and deletions (red), along with related UI labels; these changes improve readability without altering the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check86 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check115 days agoChange DetectedThe history now lists a new entry for v3.3.2 and removes the v3.2.0 revision from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial page.